Similarly, 6-gingerol has shown robust activity in metabolic disease models: it improved insulin sensitivity, reduced hepatic steatosis and lipid accumulation, and alleviated inflammation and oxidative stress in high-fat diet-fed mice and palmitate-treated HepG2 cells [26,27]. Here, INS is linked to fatty liver disease.